Agenus updates NEST Phase 2 publication in resectable colon cancer
Agenus says it has published updated Phase 2 NEST results for neoadjuvant BOT+BAL in resectable colon cancer, citing deep pathologic responses and no observed recurrences.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.